UTND Effect Mediates Macrophage Ferroptosis and Promotes Immune Microenvironment Remodeling of Ovarian Cancer

Changxin Shao1, Shiqi Qiao2, Yizi Meng1

  • 1Department of Obstetrics, Obstetrics and Gynecology Center, The First Hospital of Jilin University, Changchun, Jilin, China.

Insights

This study developed targeted nanobubbles to deliver sorafenib, inducing ferroptosis in M2 tumor-associated macrophages (TAMs). This approach repolarizes TAMs, enhances anti-tumor immunity, and improves cancer immunotherapy effectiveness.

Area of Science:

  • Oncology
  • Immunology
  • Nanomedicine

Background:

  • Tumor-associated macrophages (TAMs) create an immunosuppressive tumor microenvironment (TME), hindering cancer treatment.
  • Repolarizing TAMs and enhancing their phagocytic activity remain significant challenges in cancer therapy.
  • The role of ferroptosis in TAMs and its impact on tumor progression require further definition.

Purpose of the Study:

  • To develop M2-TAM-targeted nanobubbles for ultrasound-controlled delivery of sorafenib (SF).
  • To investigate the potential of SF-loaded nanobubbles to induce ferroptosis and repolarize M2-TAMs for enhanced cancer immunotherapy.
  • To evaluate the synergistic anti-tumor efficacy of M2-TAM-targeted ferroptosis induction combined with anti-PD-1 therapy.

Main Methods:

  • Construction of M2-TAM-targeted nanobubbles loaded with sorafenib (M2-pep@SF-NBs).
  • Utilized ultrasound (US) for controlled drug release and induction of macrophage ferroptosis.
  • Assessed the effects of M2-pep@SF-NBs on TAM repolarization, cytotoxic T lymphocyte (CTL) infiltration, and tumor growth inhibition.
  • Evaluated the combination therapy of M2-pep@SF-NBs and anti-PD-1 (aPD-1) in a tumor model.

Main Results:

  • SF-loaded nanobubbles successfully induced ferroptosis in M2-TAMs and promoted their repolarization to M1 phenotype.
  • Ultrasound-triggered ferroptosis enhanced intratumoral CTL infiltration and activated the TME, significantly inhibiting tumor growth.
  • Combination therapy with M2-pep@SF-NBs and aPD-1 demonstrated significant synergistic anti-tumor efficacy.

Conclusions:

  • M2-TAM-targeted nanobubbles offer a promising strategy for ultrasound-controlled ferroptosis induction and TAM repolarization.
  • This approach enhances macrophage-mediated cancer immunotherapy and improves the effectiveness of anti-PD-1 therapy.
  • Targeting TAM ferroptosis and function holds potential for advancing cancer prevention and therapeutic outcomes.